Concord Drugs Ltd Achieves 73.47% Monthly Gain Amid Strong Buying Activity
Concord Drugs Ltd is experiencing notable buying activity, with a significant rise in its stock price today. Over the past week and month, the company has demonstrated strong performance, consistently outperforming the Sensex and its sector. The stock is currently trading above multiple moving averages, indicating positive market sentiment.
Concord Drugs Ltd is witnessing significant buying activity, with the stock rising 4.99% today, outperforming the Sensex, which gained only 0.11%. Over the past week, Concord Drugs has shown a robust performance with a 12.21% increase, while the Sensex declined by 0.19%. The stock's impressive monthly performance stands at 73.47%, compared to the Sensex's modest 1.64% gain.Notably, Concord Drugs has been on a consecutive gain streak for the last two days, accumulating a total return of 10.4% during this period. The stock opened with a gap up of 4.03% today and reached an intraday high of Rs 55.51. It is currently just 2.32% away from its 52-week high of Rs 56.8.
Concord Drugs has consistently outperformed its sector by 5.03% today and is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This strong performance may be attributed to various factors, including market sentiment and company-specific developments, contributing to the heightened buying pressure.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
